A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study has suggested. The vaccine is designed to trigger production of a range of antibodies to fight different types of parasite causing the disease. An Edinburgh University study combined multiple versions of a protein found in many types of malaria parasite.
